Guts UK Irritable Bowel Syndrome Survey

Guts UK Irritable Bowel Syndrome Survey

Guts UK has launched a survey on the future of irritable bowel syndrome (IBS) research in the UK. Guts UK and the British Society of Gastroenterology are currently funding a Priority Setting Partnership (PSP) to identify and prioritise the unanswered questions in IBS....
Specific diets are less important for IBS

Specific diets are less important for IBS

Many IBS sufferers avoid certain diets and often exclude gluten. However, a large new study from Chalmers University of Technology and Uppsala University, Sweden, does not show a relationship between high intake of gluten and increased IBS symptoms. The researchers...
Treatment for IBS-C and IBS-D

Treatment for IBS-C and IBS-D

4D pharma plc, a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, announced new faecal microbiome analyses from the completed Phase II trial of Blautix(R) (MRx1234) as a treatment...
FDA Granted Clearance for Regulora®

FDA Granted Clearance for Regulora®

metaMe Health, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for Regulora®, the first FDA-authorized treatment of any kind specifically for abdominal pain associated with irritable bowel syndrome (IBS) in adults.  Treatment of...